248 related articles for article (PubMed ID: 32920974)
1. Endothelial JAK2V617F mutation leads to thrombosis, vasculopathy, and cardiomyopathy in a murine model of myeloproliferative neoplasm.
Castiglione M; Jiang YP; Mazzeo C; Lee S; Chen JS; Kaushansky K; Yin W; Lin RZ; Zheng H; Zhan H
J Thromb Haemost; 2020 Dec; 18(12):3359-3370. PubMed ID: 32920974
[TBL] [Abstract][Full Text] [Related]
2. JAK2V617F-Positive Endothelial Cells Induce Apoptosis and Release JAK2V617F-Positive Microparticles.
Hekimoğlu H; Toprak SF; Sözer S
Turk J Haematol; 2022 Feb; 39(1):13-21. PubMed ID: 34981912
[TBL] [Abstract][Full Text] [Related]
3. JAK2V617F mutant endothelial cells promote neoplastic hematopoiesis in a mixed vascular microenvironment.
Mazzeo C; Quan M; Wong H; Castiglione M; Kaushansky K; Zhan H
Blood Cells Mol Dis; 2021 Sep; 90():102585. PubMed ID: 34139651
[TBL] [Abstract][Full Text] [Related]
4. The JAK2V617F-bearing vascular niche promotes clonal expansion in myeloproliferative neoplasms.
Zhan H; Lin CHS; Segal Y; Kaushansky K
Leukemia; 2018 Feb; 32(2):462-469. PubMed ID: 28744010
[TBL] [Abstract][Full Text] [Related]
5. Thrombosis in myeloproliferative neoplasms with JAK2V617F mutation.
Sun T; Zhang L
Clin Appl Thromb Hemost; 2013; 19(4):374-81. PubMed ID: 22826442
[TBL] [Abstract][Full Text] [Related]
6. A Murine Model With JAK2V617F Expression in Both Hematopoietic Cells and Vascular Endothelial Cells Recapitulates the Key Features of Human Myeloproliferative Neoplasm.
Zhang H; Yeware A; Lee S; Zhan H
Front Oncol; 2021; 11():753465. PubMed ID: 34765558
[TBL] [Abstract][Full Text] [Related]
7. Endothelial Cells Harbouring the JAK2V617F Mutation Display Pro-Adherent and Pro-Thrombotic Features.
Guadall A; Lesteven E; Letort G; Awan Toor S; Delord M; Pognant D; Brusson M; Verger E; Maslah N; Giraudier S; Larghero J; Vanneaux V; Chomienne C; El Nemer W; Cassinat B; Kiladjian JJ
Thromb Haemost; 2018 Sep; 118(9):1586-1599. PubMed ID: 30103245
[TBL] [Abstract][Full Text] [Related]
8. [Myeloproliferative neoplasms and vascular diseases].
Ikeda K
Rinsho Ketsueki; 2022; 63(9):1107-1114. PubMed ID: 36198536
[TBL] [Abstract][Full Text] [Related]
9. JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms.
Etheridge SL; Roh ME; Cosgrove ME; Sangkhae V; Fox NE; Chen J; López JA; Kaushansky K; Hitchcock IS
Proc Natl Acad Sci U S A; 2014 Feb; 111(6):2295-300. PubMed ID: 24469804
[TBL] [Abstract][Full Text] [Related]
10. Clinical and laboratory significance of defective P2Y(12) pathway function in patients with myeloproliferative neoplasms: a pilot study.
Chang H; Shih LY; Michelson AD; Dunn P; Frelinger AL; Wang PN; Kuo MC; Lin TL; Wu JH; Tang TC
Acta Haematol; 2013; 130(3):181-7. PubMed ID: 23751441
[TBL] [Abstract][Full Text] [Related]
11. Unlocking the Role of Endothelial MPL Receptor and JAK2V617F Mutation: Insights into Cardiovascular Dysfunction in MPNs and CHIP.
Zhang H; Kafeiti N; Lee S; Masarik K; Zheng H; Zhan H
bioRxiv; 2023 Jul; ():. PubMed ID: 37503259
[TBL] [Abstract][Full Text] [Related]
12. The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis.
Yonal I; Pinarbası B; Hindilerden F; Hancer VS; Nalcaci M; Kaymakoglu S; Diz-Kucukkaya R
J Thromb Thrombolysis; 2012 Oct; 34(3):388-96. PubMed ID: 22569900
[TBL] [Abstract][Full Text] [Related]
13. JAK2V617F Megakaryocytes Promote Hematopoietic Stem/Progenitor Cell Expansion in Mice Through Thrombopoietin/MPL Signaling.
Zhang Y; Lin CHS; Kaushansky K; Zhan H
Stem Cells; 2018 Nov; 36(11):1676-1684. PubMed ID: 30005133
[TBL] [Abstract][Full Text] [Related]
14. Platelets and neutrophils cooperate to induce increased neutrophil extracellular trap formation in JAK2V617F myeloproliferative neoplasms.
Guy A; Garcia G; Gourdou-Latyszenok V; Wolff-Trombini L; Josserand L; Kimmerlin Q; Favre S; Kilani B; Marty C; Boulaftali Y; Labrouche-Colomer S; Mansier O; James C
J Thromb Haemost; 2024 Jan; 22(1):172-187. PubMed ID: 37678548
[TBL] [Abstract][Full Text] [Related]
15. Overview of Transgenic Mouse Models of Myeloproliferative Neoplasms (MPNs).
Dunbar A; Nazir A; Levine R
Curr Protoc Pharmacol; 2017 Jun; 77():14.40.1-14.40.19. PubMed ID: 28640953
[TBL] [Abstract][Full Text] [Related]
16. Cardiac hypertrophy associated with myeloproliferative neoplasms in JAK2V617F transgenic mice.
Shi K; Zhao W; Chen Y; Ho WT; Yang P; Zhao ZJ
J Hematol Oncol; 2014 Mar; 7():25. PubMed ID: 24646493
[TBL] [Abstract][Full Text] [Related]
17. Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis.
Smalberg JH; Arends LR; Valla DC; Kiladjian JJ; Janssen HL; Leebeek FW
Blood; 2012 Dec; 120(25):4921-8. PubMed ID: 23043069
[TBL] [Abstract][Full Text] [Related]
18. Erythrocyte-derived microvesicles induce arterial spasms in JAK2V617F myeloproliferative neoplasm.
Poisson J; Tanguy M; Davy H; Camara F; El Mdawar MB; Kheloufi M; Dagher T; Devue C; Lasselin J; Plessier A; Merchant S; Blanc-Brude O; Souyri M; Mougenot N; Dingli F; Loew D; Hatem SN; James C; Villeval JL; Boulanger CM; Rautou PE
J Clin Invest; 2020 May; 130(5):2630-2643. PubMed ID: 32045382
[TBL] [Abstract][Full Text] [Related]
19. JAK2
Lin CH; Kaushansky K; Zhan H
Blood Cells Mol Dis; 2016 Nov; 62():42-48. PubMed ID: 27865175
[TBL] [Abstract][Full Text] [Related]
20. Relationship between JAK2V617F mutation, allele burden and coagulation function in Ph-negative myeloproliferative neoplasms.
Hu L; Pu L; Ding Y; Li M; Cabanero M; Xie J; Zhou D; Yang D; Zhang C; Wang H; Zhai Z; Ru X; Li J; Xiong S
Hematology; 2017 Jul; 22(6):354-360. PubMed ID: 27976991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
